Predicta Biosciences, a precision oncology company revolutionizing diagnostic and therapeutic products with cutting-edge multiomics and liquid biopsies, has successfully raised $5.2 million in funding. The company's innovative diagnostic product portfolio aims to improve treatment decision-making for immunotherapies by offering a non-invasive alternative to bone-marrow biopsies through small blood-based samples. This recent funding will further support Predicta's mission to advance their in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development, ultimately enhancing the landscape of precision medicine in oncology. The investment will enable Predicta Biosciences to continue driving innovation in the field of oncology and bring much-needed advancements to patient care and treatment strategies.
Predicta Biosciences Secures $5.2 Million in Seed Funding to Revolutionize Precision Oncology with Multiomics and Liquid Biopsies
Recently funded 路 $5.2M SeedHealthcare
Get the full Predicta Biosciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
